Alexander KarpAlexander Karp earned $1B in 2024

In 2022, Dr. Helen I. Torley, M.B., Ch.B, M.R.C.P. earned $6.62M in total compensation at Halozyme Therapeutics, including $920.00K salary, $883.48K bonus and $4.81M in stock. Most recently sold 20,000 shares in Oct 2024. Currently holds stock worth $46.03M. Has donated $3.32M in stock to charitable causes. Has led Halozyme Therapeutics for over 11 years.

Compensation History

Annual executive compensation data for Dr. Helen I. Torley, M.B., Ch.B, M.R.C.P., including salary, bonuses, and stock awards.

Year

2022

Total Compensation

$6.62M

Salary

$920.00K

Bonus

$883.48K

Other

$0.00

Salary

$920.00K

Board Justification

The compensation philosophy aligns executive compensation with the achievement of key strategic, financial, and operational goals, emphasizing long-term performance and stockholder value.

Bonus

$883.48K

Board Justification

The annual cash incentive earned for 2022 was based on the performance of the Company against pre-established corporate performance goals, achieving approximately 107% of her target annual cash incentive opportunity.

Other Compensation

$0.00

Board Justification

Restricted Stock

$4.81M98.18K RSU

Board Justification

The number of RSUs that vested in 2022, based on the vesting schedule of 25% annually over four years following the grant date, subject to continued employment.

Performance Metrics

The performance metrics for determining the CEO's compensation included revenue growth and adjusted EBITDA targets.

H

Dr. Helen I. Torley, M.B., Ch.B, M.R.C.P.

CEO of Halozyme Therapeutics

Education

M.B.Ch.B from the University of Glasgow

Field of Expertise

Healthcare & Life Sciences - Medicine

Sector of Economy

Healthcare

Born

January 1, 1962 - 63 years ago

CEO of Halozyme Therapeutics for

11 years 11 months (Jan 2014 - Present)

Previous Experience

Executive Vice President and Chief Commercial Officer at Onyx Pharmaceuticals

Holdings

Track Dr. Helen I. Torley, M.B., Ch.B, M.R.C.P.'s stock holdings and portfolio value over time.

Total Stock Sold

$41.93M

HALO

$41.93M

911,061 HALO shares

What if they kept their stock?

If Dr. Helen I. Torley, M.B., Ch.B, M.R.C.P. didn't sell their stock, today they would have:
Extra HALO911,061 shares worth $57.70M.
This is 37.61% and $15.77M more than what they got when they sold the stock.

Charitable Transactions

HALO

52,500 shares

HALO

Recent Charitable Transactions

HALO

10,000 shares

HALO

Nov 29, 2024

Charity

HALO

10,000 shares

HALO

Mar 1, 2023

Charity

HALO

10,000 shares

HALO

Nov 30, 2020

Charity

HALO

10,000 shares

HALO

Aug 14, 2020

Charity

HALO

12,500 shares

HALO

Dec 31, 2019

Charity

Insider Trading

Dr. Helen I. Torley, M.B., Ch.B, M.R.C.P.'s recent stock transactions, purchases, and sales filed with the SEC.

HALO

10,000 shares

HALO

Nov 29, 2024

Charity

HALO

$1.07M

HALO at $53.52/share

Oct 8, 2024

Sale

HALO

$1.71M

HALO at $56.88/share

Sep 24, 2024

Sale

HALO

$1.77M

HALO at $59.13/share

Sep 10, 2024

Sale

HALO

$1.72M

HALO at $57.26/share

Aug 13, 2024

Sale

HALO

32,781 shares

HALO

Feb 15, 2024

Received

HALO

$1.28M

HALO at $42.69/share

Aug 29, 2023

Sale

HALO

$1.30M

HALO at $43.49/share

Aug 15, 2023

Sale

HALO

$1.29M

HALO at $43.09/share

Jul 25, 2023

Sale

HALO

$1.31M

HALO at $43.82/share

Mar 7, 2023

Sale

Rivals

Compare Dr. Helen I. Torley, M.B., Ch.B, M.R.C.P. with competitor CEOs and industry peers.